Percutaneous extraction of an embolized progesterone contraceptive implant from the pulmonary artery

Mohammed Majid Akhtar,1,2 Amit Bhan,2 Zhan Yun Lim,2 Mohammed Abid Akhtar,3 Neha Sekhri,2 Preeti Bharadwaj,4 Michael Mullen2 1Institute of Cardiovascular Sciences, University College London, London, UK; 2Department of Cardiology, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; 3...

Full description

Saved in:
Bibliographic Details
Main Authors: Akhtar MM (Author), Bhan A (Author), Lim ZY (Author), Akhtar MA (Author), Sekhri N (Author), Bharadwaj P (Author), Mullen M (Author)
Format: Book
Published: Dove Medical Press, 2018-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ea91938feaf420f9cac7b70a7f9f28d
042 |a dc 
100 1 0 |a Akhtar MM  |e author 
700 1 0 |a Bhan A  |e author 
700 1 0 |a Lim ZY  |e author 
700 1 0 |a Akhtar MA  |e author 
700 1 0 |a Sekhri N  |e author 
700 1 0 |a Bharadwaj P  |e author 
700 1 0 |a Mullen M  |e author 
245 0 0 |a Percutaneous extraction of an embolized progesterone contraceptive implant from the pulmonary artery 
260 |b Dove Medical Press,   |c 2018-07-01T00:00:00Z. 
500 |a 1179-1527 
520 |a Mohammed Majid Akhtar,1,2 Amit Bhan,2 Zhan Yun Lim,2 Mohammed Abid Akhtar,3 Neha Sekhri,2 Preeti Bharadwaj,4 Michael Mullen2 1Institute of Cardiovascular Sciences, University College London, London, UK; 2Department of Cardiology, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; 3Department of Cardiology and Cardiac Transplantation, Harefield Hospital, Royal Brompton & Harefield NHS Trust, London, UK; 4Community Gynaecology and Sexual & Reproductive Health Department, Waltham Forest, North East London Foundation Trust, London, UK Abstract: The Nexplanon® implant is a commonly used radiopaque contraceptive device that contains progestogen associated with an ethylene vinyl-acetate copolymer resulting in a slow release of the active hormonal ingredient. It is inserted into the subdermal connective tissue and provides contraceptive efficacy for up to 3 years. Device removal for clinical, personal or device “end-of-life span” reasons is straightforward. In rare cases, implant migration can occur locally within centimeters of the insertion site. Distant device embolization is extremely rare and can result in complications including chest pain, dyspnoea, pneumothorax and thrombosis or prevent conception until the active ingredient is depleted. We present one such case, where a Nexplanon® implant embolized into the pulmonary artery of a young female patient. We describe the initial “missed” diagnosis of embolized device on a chest radiograph and subsequent successful percutaneous removal once distant embolization was diagnosed. Keywords: Nexplanon®, pulmonary artery, embolization, extraction, snare 
546 |a EN 
690 |a Nexplanon 
690 |a Pulmonary Artery 
690 |a Embolization 
690 |a Extraction 
690 |a Snare 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Open Access Journal of Contraception, Vol Volume 9, Pp 57-61 (2018) 
787 0 |n https://www.dovepress.com/percutaneous-extraction-of-an-embolized-progesterone-contraceptive-imp-peer-reviewed-article-OAJC 
787 0 |n https://doaj.org/toc/1179-1527 
856 4 1 |u https://doaj.org/article/8ea91938feaf420f9cac7b70a7f9f28d  |z Connect to this object online.